Transcriptomics

Dataset Information

0

N6-methyladenosine RNA modification is associated with enzalutamide resistance in prostate cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE249750 | GEO | 2024/05/01

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics N6-methyladenosine RNA modification is associated with enzalutamide resistance in prostate cancer (RNA-seq)
2024-05-01 | GSE249749 | GEO
Other N6-methyladenosine RNA modification is associated with enzalutamide resistance in prostate cancer (MeRIP-Seq)
2024-05-01 | GSE249748 | GEO
Genomics N6-methyladenosine RNA modification is associated with enzalutamide resistance in prostate cancer
| PRJNA1050279 | ENA
Transcriptomics N6-methyladenosine mRNA Modification Is Essential for Human Pancreatic Lineage Specification
2022-06-13 | GSE163964 | GEO
Transcriptomics SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing in promotion of pancreatic cancer resistance to gemcitabine
2022-05-10 | GSE197533 | GEO
Other N6-methyladenosine modification is not a general trait of viral RNA genomes.
2024-01-23 | GSE231739 | GEO
Methylation profiling METTL14-mediated N6-methyladenosine modification of Col17a1/Itgα6/Itgβ4 governs epidermal homeostasis
2023-12-31 | GSE246723 | GEO
Methylation profiling N6-methyladenosine RNA modification drives a rapid shift to cisplatin resistance in bladder cancer by regulating SLC7A11 expression via YTHDF3
2023-11-08 | GSE231836 | GEO
Transcriptomics An unorthodox AR addiction drives enzalutamide resistance in prostate cancer
2020-08-20 | GSE136130 | GEO
Transcriptomics Analysis of N6-methyladenosine Methylation Modification in Fructose-induced Non-alcoholic Fatty Liver Disease
2021-10-06 | GSE185229 | GEO